Henrijette Richter
InvestorManaging Partner at Sofinnova Partners
Paris, France
Writes $100K – $5M checks · typically $1.5M
About
Managing Partner at Sofinnova Partners and member of the Sofinnova Capital Strategy team, its early-stage biotech and medtech fund. She joined in 2014 and has led life science investments including HAYA Therapeutics, Muna Therapeutics, NodThera, and Delinia (acquired by Celgene). Previously she helped build Novo Seeds from its 2007 founding and began her venture career at Sunstone Capital.
Invests in
BiotechMedical Devices
Experience
- Sofinnova PartnersManaging Partnercurrent2017 — presentGreater Paris Metropolitan Region
- Sofinnova PartnersPartner2014 — 2017Greater Paris Metropolitan Region
- Mozart Therapeutics, IncBoard Membercurrent2021 — presentSeattle, Washington, United States
- Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
- Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
- Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
- Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
- Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
- Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
- NodThera LimitedBoard Membercurrent2019 — present
- NodThera LimitedChair Of The Board Of Directors2018 — 2019
- iOmx Therapeutics AGMember of The Supervisory Boardcurrent2019 — presentGreater Munich Metropolitan Area
- iOmx Therapeutics AGChair Of The Board Of Directors2016 — 2019Greater Munich Metropolitan Area
- Asceneuron SABoard Membercurrent2015 — presentLausanne, Vaud, Switzerland
- Comet TherapeuticsMember Board Of Directors2017 — 2021
- Karolinska DevelopmentMember Board of Directors2014 — 2017Greater Stockholm Metropolitan Area
- DeliniaMember of the Board2016 — 2017San Francisco Bay Area and Cambridge Massachusetts
- DeliniaFounding Chair of the Board2015 — 2016San Francisco Bay Area and Cambridge, Massachusetts
- GUDP, Ministry of Food, Agriculture, and Fisheries of DenmarkMember Board of Directors2010 — 2016Copenhagen Metropolitan Area
- LYSOGENEMember Board of Directors2014Greater Paris Metropolitan Region
Education
- Harvard Business Schoolexecutive course, Venture Capital and Private Equity2008
- Copenhagen Business SchoolExecutive Certificate, Business Administration with focus on Leadership and Business Essentials2005 — 2006
- Massachusetts Institute of TechnologyPostdoctoral Fellow, Oncology and Cancer Biology2002 — 2004
- Københavns Universitet - University of CopenhagenPhD, Molecular Biology1999 — 2002
- Københavns Universitet - University of CopenhagenMSc, Biology1991 — 1999
Skills & more
+3 more
Pharmaceutical IndustryGrantsVenture CapitalLanguages English
From Henrijette's professional profile.
Same school
Also attended Harvard Business School1,777
+ 1,771 more
Also attended Copenhagen Business School251
+ 245 more
Also attended Massachusetts Institute of Technology849
+ 843 more
Also attended Københavns Universitet - University of Copenhagen77
+ 71 more
Shared employers
Also worked at NodThera Limited4
Also worked at iOmx Therapeutics AG1
Also worked at Delinia1
Also worked at Vaekstfonden18
+ 12 more
Investments
Investor
Avilex PharmaDeliniaEpiTherapeuticsFreya BiosciencesHAYA TherapeuticsMozart TherapeuticsMuna TherapeuticsNanoPhoria BioscienceNodTheraOrphazyme
Per the firm's website.
































